Johnson & Johnson: Wait For The Drop Or Take The Shot?
This company tracks the S&P 500 index heavily, and thus waiting for a pullback may not be a feasible strategy in a bullish marketplace. Johnson & Johnson has undoubtedly had quite a good ride over the past year.
from Biotech News
0 Comments